Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.9B | 10.2B | 9.0B | 10.6B |
Cost of revenue | 8.3B | 8.5B | 7.6B | 8.9B |
Gross profit | 1.6B | 1.8B | 1.4B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.4B | 1.2B | 1.3B |
Other operating expenses | 2M | 10M | 4M | 7M |
Operating income | 296M | 351M | 233M | 361M |
Non operating interest income | ||||
Income | 3M | 11M | 4M | 4M |
Expense | 117M | 114M | 110M | 108M |
Other income expense | — | — | — | — |
Pretax income | 194M | 267M | 133M | 262M |
Tax provision | 45M | 73M | 28M | 56M |
Net income | 149M | 195M | 105M | 206M |
Basic EPS | 1.6 | 2.1 | 1.2 | 2.2 |
Diluted EPS | 1.6 | 2.1 | 1.1 | 2.2 |
Basic average shares | 92.5M | 92.5M | 92.0M | 92.0M |
Diluted average shares | 92.9M | 92.9M | 92.4M | 92.3M |
EBITDA | 697M | 774M | 609M | 756M |
Net income from continuing op. | 194M | 267M | 133M | 262M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |